DGAP-News: Moderna, Inc.: Moderna Reviews Clinical Trial Pro

DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day 08.09.2022 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Moderna Reviews Clinical Trial Programs Across Port...

Related Keywords

United Kingdom , Cambridge , Cambridgeshire , Canada , Mary Beth Woodin , Lavina Talukdar , Seasonal Influenza Vaccine Program , World Health Organization , Young , Distribution Services , Nasdaq , Exchange Commission , Cytomegalovirus Vaccine Program , Moderna Inc , Syncytial Virus Vaccine Program , Wrd Communications , Reviews Clinical Trial Programs Across Portfolio , Chief Executive Officer , Open Label Extension , Storage Disease , Glycogen Storage Disease , Landmark Study , New Development , Influenza Vaccine Program , Southern Hemisphere , Northern Hemisphere , Stage Latent Vaccine , Vaccine Program , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Vice President , Corporate News , Regulatory Announcements , Clinical , Trial , Programs , Cross , Portfolio , R Amp D , Bay , Et Cest , The , Reviews , Linical , Mort ,